The experiments indicated that aspirin and its primary metabolic salicylic acid down-regulate cyclin A2/CDK2 proteins and c-Myc levels both transcriptional and post-transcription levels in multiple cancer cell lines, such as HCT-116, SW480, and NCI-H226 [65,66]. This evidence concerns the gene MYC and cancer.